Guidelines for the Diagnosis of Antibody‐Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema
dc.contributor.author | Drachenberg, C. B. | en_US |
dc.contributor.author | Torrealba, J. R. | en_US |
dc.contributor.author | Nankivell, B. J. | en_US |
dc.contributor.author | Rangel, E. B. | en_US |
dc.contributor.author | Bajema, I. M. | en_US |
dc.contributor.author | Kim, D. U. | en_US |
dc.contributor.author | Arend, L. | en_US |
dc.contributor.author | Bracamonte, E. R. | en_US |
dc.contributor.author | Bromberg, J. S. | en_US |
dc.contributor.author | Bruijn, J. A. | en_US |
dc.contributor.author | Cantarovich, D. | en_US |
dc.contributor.author | Chapman, J. R. | en_US |
dc.contributor.author | Farris, A. B. | en_US |
dc.contributor.author | Gaber, L. | en_US |
dc.contributor.author | Goldberg, J. C. | en_US |
dc.contributor.author | Haririan, A. | en_US |
dc.contributor.author | Honsová, E. | en_US |
dc.contributor.author | Iskandar, S. S. | en_US |
dc.contributor.author | Klassen, D. K. | en_US |
dc.contributor.author | Kraus, E. | en_US |
dc.contributor.author | Lower, F. | en_US |
dc.contributor.author | Odorico, J. | en_US |
dc.contributor.author | Olson, J. L. | en_US |
dc.contributor.author | Mittalhenkle, A. | en_US |
dc.contributor.author | Munivenkatappa, R. | en_US |
dc.contributor.author | Paraskevas, S. | en_US |
dc.contributor.author | Papadimitriou, J. C. | en_US |
dc.contributor.author | Randhawa, P. | en_US |
dc.contributor.author | Reinholt, F. P. | en_US |
dc.contributor.author | Renaudin, K. | en_US |
dc.contributor.author | Revelo, P. | en_US |
dc.contributor.author | Ruiz, P. | en_US |
dc.contributor.author | Samaniego, Millie D. | en_US |
dc.contributor.author | Shapiro, R. | en_US |
dc.contributor.author | Stratta, R. J. | en_US |
dc.contributor.author | Sutherland, David E. R. | en_US |
dc.contributor.author | Troxell, M. L. | en_US |
dc.contributor.author | Voska, L. | en_US |
dc.contributor.author | Seshan, S. V. | en_US |
dc.contributor.author | Racusen, L. C. | en_US |
dc.contributor.author | Bartlett, S. T. | en_US |
dc.date.accessioned | 2011-11-10T15:38:41Z | |
dc.date.available | 2012-11-02T18:56:49Z | en_US |
dc.date.issued | 2011-09 | en_US |
dc.identifier.citation | Drachenberg, C. B.; Torrealba, J. R.; Nankivell, B. J.; Rangel, E. B.; Bajema, I. M.; Kim, D. U.; Arend, L.; Bracamonte, E. R.; Bromberg, J. S.; Bruijn, J. A.; Cantarovich, D.; Chapman, J. R.; Farris, A. B.; Gaber, L.; Goldberg, J. C.; Haririan, A.; Honsová, E. ; Iskandar, S. S.; Klassen, D. K.; Kraus, E.; Lower, F.; Odorico, J.; Olson, J. L.; Mittalhenkle, A.; Munivenkatappa, R.; Paraskevas, S.; Papadimitriou, J. C.; Randhawa, P.; Reinholt, F. P.; Renaudin, K.; Revelo, P.; Ruiz, P.; Samaniego, M. D.; Shapiro, R.; Stratta, R. J.; Sutherland, D. E. R.; Troxell, M. L.; Voska, L.; Seshan, S. V.; Racusen, L. C.; Bartlett, S. T. (2011). "Guidelines for the Diagnosis of Antibodyâ Mediated Rejection in Pancreas Allograftsâ Updated Banff Grading Schema." American Journal of Transplantation 11(9). <http://hdl.handle.net/2027.42/87117> | en_US |
dc.identifier.issn | 1600-6135 | en_US |
dc.identifier.issn | 1600-6143 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/87117 | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Acinar Cell Injury | en_US |
dc.subject.other | Active Chronic Antibody‐Mediated Rejection | en_US |
dc.subject.other | Amylin | en_US |
dc.subject.other | Amyloid | en_US |
dc.subject.other | C4d | en_US |
dc.subject.other | Cell‐Mediated Rejection | en_US |
dc.subject.other | Donor‐Specific Antibody | en_US |
dc.subject.other | Interacinar Capillaries | en_US |
dc.subject.other | Pancreas Biopsy | en_US |
dc.subject.other | Transplant Arteriopathy | en_US |
dc.title | Guidelines for the Diagnosis of Antibody‐Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Maryland School of Medicine, Baltimore, MD | en_US |
dc.contributor.affiliationother | Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin‐Madison, Madison, WI | en_US |
dc.contributor.affiliationother | Department of Renal Medicine, University of Sidney, Westmead Hospital, Sydney, Australia | en_US |
dc.contributor.affiliationother | Pancreas‐Kidney Transplantation Unit, Hospital Israelita Albert Einstein, HIAE, San Paulo, Brazil | en_US |
dc.contributor.affiliationother | Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands | en_US |
dc.contributor.affiliationother | Department of Pathology, Saint Barnabas Medical Center, Livingston, NJ | en_US |
dc.contributor.affiliationother | Department of Pathology (L.A. and L.C.R.) and Internal Medicine (E.K.), Johns Hopkins University, Baltimore, MD | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Arizona, Tucson, AZ | en_US |
dc.contributor.affiliationother | Department of Surgery, University of Maryland School of Medicine, Baltimore, MD | en_US |
dc.contributor.affiliationother | Department of Nephrology (D.C.) and Department of Pathology (K.R.) CHU – Hôtel Dieu, Nantes, France | en_US |
dc.contributor.affiliationother | Department of Pathology, Emory University School of Medicine, Atlanta, GA | en_US |
dc.contributor.affiliationother | Department of Pathology, The Methodist Hospital, Weil Cornell Medical College, Houston, TX | en_US |
dc.contributor.affiliationother | Instituto de Nefrologia, Buenos Aires, Argentina | en_US |
dc.contributor.affiliationother | Department of Medicine, University of Maryland School of Medicine, Baltimore, MD | en_US |
dc.contributor.affiliationother | Department of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic | en_US |
dc.contributor.affiliationother | Department of Pathology (S.I.) and General Surgery (R.J.S.) Wake Forest University School of Medicine, Winston‐Salem, NC | en_US |
dc.contributor.affiliationother | Southern Illinois University School of Medicine, Springfield, IL | en_US |
dc.contributor.affiliationother | Department of Surgery, School of Medicine and Public Health, University of Wisconsin‐Madison, Madison, WI | en_US |
dc.contributor.affiliationother | Department of Pathology, University of California, San Francisco, CA | en_US |
dc.contributor.affiliationother | Department of Medicine (A.M.) and Department of Pathology (M.L.T.), Division of Nephrology & Hypertension, Oregon Health & Science University, Portland, OR | en_US |
dc.contributor.affiliationother | Department of Surgery, McGill University, Montreal, Quebec, Canada | en_US |
dc.contributor.affiliationother | Department of Pathology (P.R.) and Department of Surgery (R.S.), Division of Transplantation Pathology, University of Pittsburgh, Pittsburgh, PA | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway | en_US |
dc.contributor.affiliationother | Department of Pathology and Laboratory Medicine, University of Utah, Salt Lake City, UT | en_US |
dc.contributor.affiliationother | Departments of Pathology and Surgery, University of Miami, Miami, FL | en_US |
dc.contributor.affiliationother | Department of Surgery, Division of Transplantation and Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, MN | en_US |
dc.contributor.affiliationother | Department of Pathology, Weil Cornell Medical College, New York, NY | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/87117/1/j.1600-6143.2011.03670.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-6143.2011.03670.x | en_US |
dc.identifier.source | American Journal of Transplantation | en_US |
dc.identifier.citedreference | Gruessner AC, Sutherland DE, Gruessner RW. Pancreas transplantation in the United States: A review. Curr Opin Organ Transplant 2010; 15: 93 – 101. | en_US |
dc.identifier.citedreference | Drachenberg CB, Papadimitriou JC, Farney A, et al. Pancreas transplantation: The histologic morphology of graft loss and clinical correlations. Transplantation 2001; 71: 1784 – 1791. | en_US |
dc.identifier.citedreference | Luan FL, Trillsch F, Henger A, et al. A pilot study of gene expression‐based categorization of pancreas transplant biopsies. Transplantation 2009; 87: 222 – 226. | en_US |
dc.identifier.citedreference | Nakhleh RE, Sutherland DE. Biopsies from pancreas allografts at time of dysfunction: Pathologic comparison of allografts which ultimately failed versus those which continued to function. Transplant Proc 1993; 25 ( 1 Pt 2 ): 1194 – 1195. | en_US |
dc.identifier.citedreference | Papadimitriou JC, Drachenberg CB, Klassen DK, et al. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant 2003; 3: 599 – 605. | en_US |
dc.identifier.citedreference | Torrealba JR, Samaniego M, Pascual J, et al. C4d‐positive interacinar capillaries correlates with donor‐specific antibody‐mediated rejection in pancreas allografts. Transplantation 2008; 86: 1849 – 1856. | en_US |
dc.identifier.citedreference | Troxell ML, Koslin DB, Norman D, et al. Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow‐up biopsies. Transplantation 2010; 90: 75 – 84. | en_US |
dc.identifier.citedreference | Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579 – 1586. | en_US |
dc.identifier.citedreference | Drachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: Working proposal by a multi‐disciplinary international consensus panel. Am J Transplant 2008; 8: 1237 – 1249. | en_US |
dc.identifier.citedreference | Waki K, Terasaki PI, Kadowaki T. Long term pancreas allograft survival in simultaneous pancreas kidney transplantation by era: UNOS registry analysis. Diabetes Care 2010; 33: 1789 – 1791. | en_US |
dc.identifier.citedreference | Pascual J, Samaniego MD, Torrealba JR, et al. Antibody‐mediated rejection of the kidney after simultaneous pancreas‐kidney transplantation. J Am Soc Nephrol 2008; 19: 812 – 824. | en_US |
dc.identifier.citedreference | de Kort H, Munivenkatappa RB, Berger SP, et al. Pancreas allograft biopsies with positive C4d staining and anti‐donor antibodies related to worse outcome for patients. Am J Transplant 2010; 10: 1660 – 1667. | en_US |
dc.identifier.citedreference | Melcher ML, Olson JL, Baxter‐Lowe LA, et al. Antibody‐mediated rejection of a pancreas allograft. Am J Transplant 2006; 6: 423 – 428. | en_US |
dc.identifier.citedreference | Munivenkatappa RB, Philosophe B, Papadimitriou JC, et al. Interacinar c4d staining in pancreas allografts. Transplantation 2009; 88: 145 – 146. | en_US |
dc.identifier.citedreference | Rangel EB, Malheiros DM, de Castro MC, et al. Antibody‐mediated rejection (AMR) after pancreas and pancreas‐kidney transplantation. Transpl Int 2010; 23: 602 – 610. | en_US |
dc.identifier.citedreference | Colvin RB. Dimensions of antibody‐mediated rejection. Am J Transplant 2010; 10: 1509 – 1510. | en_US |
dc.identifier.citedreference | Colvin RB. Antibody‐mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046 – 1056. | en_US |
dc.identifier.citedreference | Gaber LW. Pancreas allograft biopsies in the management of pancreas transplant recipients: Histopathologic review and clinical correlations. Arch Pathol Lab Med 2007; 131: 1192 – 1199. | en_US |
dc.identifier.citedreference | Fabio V, Daniele F, Monica DD, et al. Pancreas rejection after pandemic influenzavirus A(H(1) N(1)) vaccination or infection: A report of two cases. Transpl Int 2011; 24: e28 – e29. | en_US |
dc.identifier.citedreference | Zanone MM, Favaro E, Quadri R, et al. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient. Transpl Int 2010; 23: 333 – 337. | en_US |
dc.identifier.citedreference | Einecke G, Sis B, Reeve J, et al. Antibody‐mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520 – 2531. | en_US |
dc.identifier.citedreference | Papadimitriou JC, Drachenberg CB, Munivenkatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year: Cell types and relationship with antibody‐mediated rejection and graft outcome. Transplantation 2010; 90: 1478 – 1485. | en_US |
dc.identifier.citedreference | Everly MJ, Rebellato LM, Ozawa M, et al. Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 2010; 89: 962 – 967. | en_US |
dc.identifier.citedreference | Terasaki PI. The review by Kwun and Knechtle‐“can it B?” ‐asks whether B cells are responsible for chronic rejection of transplants. Transplantation 2009; 88; 978 – 979. | en_US |
dc.identifier.citedreference | Porcheray F, DeVito J, Yeap BY, et al. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239 – 1246. | en_US |
dc.identifier.citedreference | Pelletier RP, Hennessy PK, Adams PW, et al. Clinical significance of MHC‐reactive alloantibodies that develop after kidney or kidney‐pancreas transplantation. Am J Transplant 2002; 2: 134 – 141. | en_US |
dc.identifier.citedreference | Daar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984; 38: 293 – 298. | en_US |
dc.identifier.citedreference | Daar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of HLA‐A, B, C antigens in normal human organs. Transplantation 1984; 38: 287 – 292. | en_US |
dc.identifier.citedreference | Fleming KA, McMichael A, Morton JA, et al. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981; 34: 779 – 784. | en_US |
dc.identifier.citedreference | Jackson AM, Connolly JE, Matsumoto S, et al. Evidence for induced expression of HLA Class II on human islets: Possible mechanism for HLA sensitization in transplant recipients. Transplantation 2009; 87: 500 – 506. | en_US |
dc.identifier.citedreference | Pavlovic D, van de Winkel M, van der Auwera B, et al. Effect of interferon‐gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta‐ and non‐beta‐cells. J Clin Endocrinol Metab 1997; 82: 2329 – 2336. | en_US |
dc.identifier.citedreference | Pujol‐Borrell R, Todd I, Doshi M, Gray D, et al. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 1986; 65: 128 – 139. | en_US |
dc.identifier.citedreference | Steiniger B, Klempnauer J, Wonigeit K. Altered distribution of class I and class II MHC antigens during acute pancreas allograft rejection in the rat. Transplantation 1985; 40: 234 – 239. | en_US |
dc.identifier.citedreference | Foulis AK, Farquharson MA, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin‐dependent) diabetes mellitus. Diabetologia 1987; 30: 333 – 343. | en_US |
dc.identifier.citedreference | Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody‐mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68 – 74. | en_US |
dc.identifier.citedreference | Howell WM, Harmer A, Briggs D, et al. British Society for Histocompatibility & Immunogenetics and British Transplantation Society guidelines for the detection and characterisation of clinically relevant antibodies in allotransplantation. Int J Immunogenet 2010; 37: 435 – 437. | en_US |
dc.identifier.citedreference | Zeevi A, Lunz JG, 3rd, Shapiro R, et al. Emerging role of donor‐specific anti‐human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009; 70: 645 – 650. | en_US |
dc.identifier.citedreference | Leffell MS, Zachary AA. Antiallograft antibodies: Relevance, detection, and monitoring. Curr Opin Organ Transplant 2010; 15: 2 – 7. | en_US |
dc.identifier.citedreference | Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney‐transplant rejection. N Engl J Med 2007; 357: 1293 – 1300. | en_US |
dc.identifier.citedreference | Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464 – 1475. | en_US |
dc.identifier.citedreference | Minami K, Murata K, Lee CY, et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006; 6 ( 5 Pt 1 ): 923 – 932. | en_US |
dc.identifier.citedreference | Halloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215 – 2222. | en_US |
dc.identifier.citedreference | Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d‐negative antibody‐mediated rejection. Curr Opin Organ Transplant 2010; 15: 42 – 48. | en_US |
dc.identifier.citedreference | Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor‐specific antibodies (DSA). Am J Transplant 2011; 11: 56 – 65. | en_US |
dc.identifier.citedreference | Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753 – 760. | en_US |
dc.identifier.citedreference | Miller DV, Roden AC, Gamez JD, et al. Detection of C4d deposition in cardiac allografts: A comparative study of immunofluorescence and immunoperoxidase methods. Arch Pathol Lab Med 2010; 134: 1679 – 1684. | en_US |
dc.identifier.citedreference | Haririan A, Kiangkitiwan B, Kukuruga D, et al. The impact of c4d pattern and donor‐specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758 – 2767. | en_US |
dc.identifier.citedreference | Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: Univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285 – 316. | en_US |
dc.identifier.citedreference | Sibley RK. Pancreas transplantation. In: Sale GE, ed. The pathology of organ transplantation. Boston: Butterworth Publishers, 1990: 179 – 215. | en_US |
dc.identifier.citedreference | Hawthorne WJ, Griffin AD, Lau H, et al. Experimental hyperacute rejection in pancreas allotransplants. Transplantation 1996; 62: 324 – 329. | en_US |
dc.identifier.citedreference | Heilman RL, Chakkera H, Mazur M, et al. Outcomes of simultaneous kidney‐pancreas transplantation with positive cross‐match. Transplant Proc 2009; 41: 303 – 306. | en_US |
dc.identifier.citedreference | Khwaja K, Wijkstrom M, Gruessner A, et al. Pancreas transplantation in crossmatch‐positive recipients. Clin Transplant 2003; 17: 242 – 248. | en_US |
dc.identifier.citedreference | Litmathe J, Bektas H, Jorns A, et al. Time frame of pancreas allograft rejection: An immunogenetic analysis in MHC‐disparate, presensitized inbred rat strains. Transplant Proc 2003; 35: 3147 – 3152. | en_US |
dc.identifier.citedreference | Pascual J, Pirsch JD, Odorico JS, et al. Alemtuzumab induction and antibody‐mediated kidney rejection after simultaneous pancreas‐kidney transplantation. Transplantation 2009; 87: 125 – 132. | en_US |
dc.identifier.citedreference | Prikis M, Norman D, Rayhill S, et al. Preserved endocrine function in a pancreas transplant recipient with pancreatic panniculitis and antibody‐mediated rejection. Am J Transplant 2010; 10: 2717 – 2722. | en_US |
dc.identifier.citedreference | Gibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819 – 825. | en_US |
dc.identifier.citedreference | Liptak P, Kemeny E, Morvay Z, et al. Peritubular capillary damage in acute humoral rejection: An ultrastructural study on human renal allografts. Am J Transplant 2005; 5: 2870 – 2876. | en_US |
dc.identifier.citedreference | Carbajal R, Karam G, Renaudin K, et al. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation. Nephrol Dial Transplant 2007; 22: 942 – 944. | en_US |
dc.identifier.citedreference | Hirohashi T, Uehara S, Chase CM, et al. Complement independent antibody‐mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510 – 517. | en_US |
dc.identifier.citedreference | Shimizu T, Ishida H, Shirakawa H, et al. Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 2010; 24 ( Suppl 22 ): 22 – 26. | en_US |
dc.identifier.citedreference | Sis B, Einecke G, Chang J, et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010; 10: 421 – 430. | en_US |
dc.identifier.citedreference | Vendrame F, Pileggi A, Laughlin E, et al. Recurrence of type 1 diabetes after simultaneous pancreas‐kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T‐cells. Diabetes 2010; 59: 947 – 957. | en_US |
dc.identifier.citedreference | Tyden G, Reinholt FP, Sundkvist G, et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860 – 863. | en_US |
dc.identifier.citedreference | Cai K, Qi D, Wang O, et al. TNF‐alpha acutely upregulates amylin expression in murine pancreatic beta cells. Diabetologia 2011; 54: 617 – 626. | en_US |
dc.identifier.citedreference | Jaikaran ET, Clark A. Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001; 1537: 179 – 203. | en_US |
dc.identifier.citedreference | Sis B, Mengel M, Haas M, et al. Banff ‘09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464 – 471. | en_US |
dc.identifier.citedreference | Halloran PF, de Freitas DG, Einecke G, et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010; 10: 2223 – 2230. | en_US |
dc.identifier.citedreference | Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody‐mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312 – 2323. | en_US |
dc.identifier.citedreference | Stegall MD, Gloor JM. Deciphering antibody‐mediated rejection: New insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15: 8 – 10. | en_US |
dc.identifier.citedreference | Mengel M, Sis B, Halloran PF. SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221 – 2226. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.